“One person can and will find a way
why not be that person?”
Press Release
Complete Enrollment Achieved for the Clinical Phase 2 ASURE Study: Advancing Alzheimer’s Disease Research
Therapy development
Treeway is a clinical-stage biotechnology company founded by two ALS patients, Bernard Muller and Robbert Jan Stuit in 2012. Our mission is to develop therapies for ALS, Alzheimer’s disease and other neurodegenerative diseases.
Pipeline
We are currently developing therapies in preclinical and clinical stages to slow down the progression and ultimately cure ALS and other neurodegenerative diseases. For our discovery research, we collaborate closely with globally recognized academic institutes with long-standing expertise in the field of neurodegenerative diseases and drug development.
TW001 (FNP122 for Ferrer) Oral Edaravone for ALS
- Preclinical
- Phase 1
- Phase 2
- Phase 3
The phase 3 study ADORE is owned and sponsored by Ferrer
TW101 Oral Edaravone for Alzheimer’s disease
- Preclinical
- Phase 1
- Phase 2
- Phase 3
TW201 for opthalmological indication
- Preclinical
- Phase 1
- Phase 2
- Phase 3
Combination treatment for Alzheimer’s disease
- Preclinical
- Phase 1
- Phase 2
- Phase 3
New targets for ALS
- Preclinical
- Phase 1
- Phase 2
- Phase 3
Our expertise
Treeway’s team is comprised of accomplished experts who worked in the top 10 European pharmaceutical companies.
Pipeline
You cannot take any short cuts in drug development for ALS and Alzheimer’s disease, but you can be smart.
Our partners
Collaborations are a catalyst for innovation and are therefore a key factor for Treeway’s success.
We are proud to have collaborated with national and international pharmaceutical companies, NGOs, and several universities and research centers in the Netherlands, Europe, Asia and the United States. Treeway is actively seeking new collaborations and partnerships with companies and organizations who share in our drive and passion for effective drug development for neurodegenerative diseases such as ALS and Alzheimer’s disease.
Get actively involved with us.
Treeway is always looking for talent that can help us with our mission. We want to radically impact the lives of patients with neurodegenerative diseases and together we can put our vision into practice. To connect with the ALS patient community, we are happy to direct you to our partnering ALS associations.
